Jeffrey S. Murray, MD, MPH, is Deputy Director of the Division of Antiviral Products (DAVP) at the US Food and Drug Administration. He has worked in the Division in various capacities for over 25 years. At DAVP, Dr. Murray has reviewed and approved marketing applications for drugs to treat and/or prevent HIV, influenza, herpes viruses, hepatitis B and C. He has co-authored publications and FDA guidance documents for HIV drug development, HIV fixed dose combinations for the President's Emergency Plan for AIDS Relief (PEPFAR) and the development of drugs for the treatment of Influenza and Chronic Hepatitis C. Dr. Murray received his MD from The Ohio State University and his MPH from George Washington University in Washington, DC. He completed his internship, residency and chief residency in Internal Medicine at Riverside Methodist Hospitals in Columbus, followed by a fellowship in Infectious Diseases at the University of Cincinnati Medical Center.